MitraClip / Transcatheter Edge-to-Edge Repair (TEER) Procedure for International Patients in India
The complete planning guide: primary versus secondary mitral regurgitation, who is suitable for a clip, TEE assessment of leaflet anatomy, the procedure, residual MR and gradient, complications, TEER versus surgery, choosing your Heart Team, cost and follow-up at home
Transcatheter edge-to-edge repair (TEER) is a catheter-based treatment for selected patients with significant mitral regurgitation (MR). MitraClip is the best-known TEER system. Instead of replacing the mitral valve, the device grasps and joins portions of the anterior and posterior mitral leaflets, creating a more effective seal and reducing backward leakage.
TEER is not simply a less invasive substitute for mitral surgery. The correct choice depends on whether MR is primary/degenerative or secondary/functional, the patient's symptoms and ventricular function, whether guideline-directed medical therapy has been optimized, surgical risk, leaflet anatomy, mitral valve area/gradient, pulmonary pressure and the likelihood of achieving a durable reduction in MR without creating mitral stenosis. Being told that a leaking mitral valve may be treated with a clip can sound like an easy answer, and planning it abroad adds more questions. This guide is written to help you ask the questions that matter, understand what a sound plan looks like and recognize when it is safer to be stabilized locally first. It does not promise outcomes: every heart, valve and recovery is different.
Short Answer: Is India a Good Option for Mitraclip / Teer?
For many clinically stable patients with confirmed severe mitral regurgitation and a Heart Team recommendation for TEER, yes. TEER is catheter-based and usually done through a vein in the groin, so the stay in India is much shorter than after open-heart surgery, often about 7-14 days. Tertiary Indian centres have structural-heart teams, 3D echocardiography and cardiac surgery backup, and private self-pay care is generally cheaper than in the USA, UK or Australia, although the imported device is a major cost. The key question is whether a clip is right for your valve: primary or secondary MR, leaflet anatomy on TEE, and whether expert surgical repair or optimized heart-failure treatment would serve you better. Unstable patients should be treated locally first. Send your original TEE images for a remote review.
Quick Facts - MitraClip / TEER Procedure for International Patients in India
| Topic | Planning Point |
|---|---|
| Treats | Selected severe symptomatic mitral regurgitation |
| Device concept | Clips mitral leaflets together; does not replace the valve |
| Main pathways | Primary/degenerative MR and secondary/functional MR have different selection criteria |
| Access | Usually femoral vein with transseptal puncture into left atrium |
| Imaging | TEE, often 3D TEE, plus fluoroscopy |
| Anaesthesia | Commonly general anaesthesia; protocols vary |
| Heart-lung machine | Not routinely required |
| Hospital stay | Often about 2-4 days if uncomplicated |
| International stay | Often about 7-14 days; individualized |
| Major risks | Bleeding/vascular injury, stroke, tamponade, leaflet injury, residual MR, single-leaflet device attachment, mitral stenosis and death |
| Key success measure | Meaningful MR reduction without excessive transmitral gradient |
| Alternatives to consider | Expert surgical repair, mitral valve replacement, and optimized heart-failure drugs, CRT or revascularization for secondary MR |
| Records to send | TTE and TEE images and reports (original TEE images especially), ECG, coronary studies, heart-failure medicines, CRT or device data, prior cardiac surgery records, kidney function and recent hospitalizations |
| Major Indian hubs | Delhi NCR, Mumbai, Bengaluru, Chennai, Hyderabad and other tertiary cardiac centres |
| Companion | Advisable, especially for frail or heart-failure patients; an attendant visa can be arranged |
How This Guide Is Organised
- Part 1 - Why India, and understanding mitral regurgitation and TEER
- Part 2 - Tests, anatomy and risk
- Part 3 - The procedure step by step
- Part 4 - Results, residual MR and complications
- Part 5 - Hospital recovery and early benefit
- Part 6 - Antithrombotic therapy, follow-up and recurrent MR
- Part 7 - TEER versus surgery and valve replacement
- Part 8 - Choosing your Heart Team, hospital and city
- Part 9 - Expected outcomes and what to expect
- Part 10 - Cost, packages and quotations
- Part 11 - Your journey: records, travel, visa and going home
- Part 12 - Tools: questions, candidacy, FAQ and checklist
Why India, and Understanding Mitral Regurgitation and TEER
Why Do International Patients Choose India for MitraClip / TEER?
Patients travel for TEER for practical reasons, and the strongest ones are about reaching an experienced structural-heart team and a complete mitral centre at a price that does not force a compromise on safety:
- Lower cost. Private Indian hospitals often quote less than self-pay prices in the USA, UK, Australia and other high-cost markets. The imported device is a major cost, so the saving is smaller than for some surgery, and the number of clips, a complication or a longer stay can change the final bill.
- Structural-heart programs. Major cities have tertiary centres with interventional cardiologists, expert echocardiographers, cardiac surgeons and heart-failure specialists working as a Heart Team.
- TEER, surgical repair and replacement in one place. A complete mitral centre can recommend surgery or medical therapy when they are better, rather than offering only the clip.
- Advanced imaging. 3D TEE and experienced imaging teams are central to selecting patients and guiding the clip.
- A shorter stay than surgery. Uncomplicated TEER often fits within roughly 7-14 days including assessment and early review.
- Shorter waits. Private care can often be scheduled promptly after a remote review.
- International patient support and English-speaking teams. Major hospitals typically help with appointments, hospital letters for visas, airport pick-up and accommodation guidance.
- A plan you can review first. A remote review of your original TEE images can tell you whether a clip looks feasible and sensible, before you commit to travel. Device availability should be confirmed with the centre.
Urgent Problems Should Not Wait for Travel
Cardiogenic shock, severe pulmonary edema, unstable arrhythmia and active endocarditis need urgent local stabilization. International travel should not delay emergency treatment.
How Does India Compare with Other Medical Travel Destinations?
Many patients also look at heart centres in other countries before deciding. There is no single best country for every patient; the right choice depends on where you live, your diagnosis and what you can verify about the team and the hospital. These are the factors worth comparing:
| Factor | What to compare | How India generally fares |
|---|---|---|
| Cost | The full itemized package: device and number of clips included, imaging, interventional fee, cath or hybrid lab, ICU or room days and exclusions | Generally lower than self-pay pricing in Western countries, though the device is a large share of the cost, so the difference can be modest |
| Heart Team and operator experience | Dedicated mitral TEER volume, expert echocardiographers and a mitral surgeon who takes part in the decision | Experienced structural programs exist in major cities; ask for volumes and outcomes |
| Hospital level | Advanced 3D TEE, structural intervention, cardiac surgery, anaesthesia, ICU, heart-failure services and emergency surgical capability | Tertiary cardiac centres in major cities generally offer these; ask for specifics |
| Device availability | Which TEER system is proposed and how many clips are included | Confirm the exact device and availability with the centre |
| Follow-up | Who will manage echocardiography and heart-failure therapy at home | Needs advance agreement and a named cardiologist |
| Distance and stay | Length of the flight and the 7-14 days or more you may need to stay | Depends on where you live: relatively close for patients from South Asia, the Middle East and East Africa, and a long-haul journey from the Americas and parts of Europe |
| Visa | Visa type, processing time and attendant visa rules | India has a dedicated medical visa system with attendant categories; always confirm current rules for your nationality |
| Emergency access | Surgical backup for tamponade, leaflet injury or uncontrolled MR | Choose a centre with cardiac surgery on site; confirm in writing |
A Fair Way to Compare Destinations
- Ask every centre for the same written plan: MR mechanism and severity, TEER versus surgery rationale, device, number of clips included, extra clip price and exclusions.
- Compare Heart Team quality, TEER volume and surgical backup first and the price second.
- Compare the total pathway cost: tests, the device and procedure, a possible extra clip or complication, flights, accommodation and a companion.
- Judge the quality of the plan, including what happens if MR recurs and how future surgery is preserved.
- Compare the follow-up plan: who will manage echocardiography and heart-failure therapy after you return home?
What Is Mitral Regurgitation?
MR is backward leakage of blood from the left ventricle into the left atrium during contraction. Severe MR can cause breathlessness, fatigue, pulmonary hypertension, atrial fibrillation, ventricular dysfunction and recurrent heart-failure admissions.
Primary vs Secondary MR
Primary MR is caused by structural leaflet/chordal disease such as prolapse or flail. Secondary MR results mainly from ventricular or atrial remodeling that prevents otherwise relatively normal leaflets from coapting. TEER selection differs substantially between these groups.
What Is TEER?
A catheter system is advanced from a femoral vein to the right atrium, across the interatrial septum and into the left atrium. One or more clips grasp the mitral leaflets at the regurgitant jet to improve coaptation.
MitraClip vs TEER
TEER describes the treatment concept. MitraClip is a specific commercial TEER device. Other edge-to-edge systems also exist in some markets, so the treating center should identify the exact device being proposed.
What TEER Does Not Do
TEER does not remove diseased leaflets, replace the annulus, perform a surgical ring annuloplasty, treat coronary disease or repair other valves. These limitations matter when surgery could address several problems at once.
Who May Be Considered With Primary MR?
TEER may be considered for selected symptomatic patients with severe primary MR who are at high or prohibitive surgical risk and have favorable anatomy. In an operable patient with repairable degenerative MR, expert surgical repair can remain the preferred durable strategy.
Who May Be Considered With Secondary MR?
Selected patients with severe symptomatic secondary MR despite optimized guideline-directed heart-failure therapy may benefit from TEER when anatomy and ventricular characteristics are appropriate. Heart-failure specialists should optimize treatment before labeling the patient a TEER candidate.
Why Medical Therapy Comes First in Secondary MR
Secondary MR is often a consequence of ventricular disease. Guideline-directed heart-failure drugs, revascularization when appropriate and CRT in eligible patients can reduce MR by improving ventricular geometry. TEER is considered when significant MR and symptoms persist.
TEER and CRT
Patients with reduced ejection fraction and electrical dyssynchrony may improve with cardiac resynchronization therapy. If CRT is indicated, its effect should generally be assessed before proceeding to TEER unless clinical urgency dictates otherwise.
When Surgery May Be Better
Surgery may be favored in an operable patient with highly repairable degenerative MR, when CABG or another valve operation is needed, when anatomy is unsuitable for clipping, or when a durable surgical repair is expected to offer better long-term results.
When TEER May Not Help
Advanced irreversible ventricular failure, severe right-heart failure, extreme pulmonary vascular disease or major non-cardiac illness can limit benefit even if clipping is technically possible. The team should assess likely survival and quality-of-life gain.
Symptoms and Functional Assessment
Breathlessness, fatigue, reduced walking distance, edema and recurrent admissions are important. NYHA functional class, exercise tolerance and quality-of-life measures help establish baseline severity and later response.
Is TEER Right for You? A Short Checklist
| Question | Why it matters | Who answers it |
|---|---|---|
| Is my MR primary or secondary, and is it definitely severe? | Selection criteria differ substantially between the two | A cardiologist, with echocardiography and TEE |
| Do I have symptoms despite optimized heart-failure treatment? | In secondary MR, drugs, CRT and revascularization come first | A heart-failure specialist |
| Can an expert surgeon repair my valve durably? | In operable degenerative MR, surgical repair may remain preferred | A mitral repair surgeon |
| Does my leaflet anatomy suit a clip? | Short, calcified or complex leaflets reduce success | An expert echocardiographer, with 3D TEE |
| Do I need CABG, another valve procedure or CRT as well? | TEER does not treat coronary disease or other valves | The Heart Team |
| What happens if MR recurs, and what about future surgery? | Prior clips can make later repair more difficult | The Heart Team, with you |
Preparing Yourself Before TEER (Prehab)
Preparation reduces risk. Always agree what is appropriate with your cardiologist, and never let preparation delay urgent treatment:
- Collecting your TTE and TEE images and reports, ECG, coronary studies and previous cardiac records, and asking for copies of the original TEE images
- Taking your heart-failure and other heart medicines exactly as prescribed, and not stopping any, including blood thinners, without advice
- Seeing your dentist and treating any dental infection before the procedure, as device infection is rare but serious
- Controlling diabetes and blood pressure, and stopping smoking
- Staying active and walking within the limits your cardiologist advises, and reporting any new breathlessness, swelling or fainting
- Looking after nutrition and treating anemia if present
- Writing down your medicine list, allergies, CRT or pacemaker details and previous operations
- Finding a home cardiologist and heart-failure service who will receive your reports and echocardiogram
- Planning a companion, accommodation near the hospital and flexible flights
Preparation should never delay urgent treatment. Your cardiologist will tell you if time is critical.
Tests, Anatomy and Risk
Transthoracic Echocardiography
TTE quantifies MR, ventricular size/function, left-atrial size, pulmonary pressure, tricuspid regurgitation and other valve disease. MR severity should be integrated from multiple measurements rather than a single number.
Transesophageal Echocardiography
TEE is central to TEER planning because it defines leaflet length, flail/prolapse, jet location, calcification, clefts and baseline mitral valve area. Three-dimensional imaging is especially valuable.
Why Anatomy Matters
A clip needs enough mobile leaflet tissue to achieve secure grasping. Very short leaflets, severe calcification in the grasping zone, large gaps, complex clefts or extensive disease can reduce procedural success.
Jet Location
Central A2-P2 pathology is often technically favorable, but experienced teams can treat selected noncentral lesions. Multiple jets or commissural disease may require more complex strategy.
Flail Gap and Flail Width
Large flail segments can be more challenging because the leaflets are widely separated. Device generation, clip size and operator experience influence feasibility.
Leaflet Calcification
Calcification where the clip must grasp can prevent secure leaflet capture and increase residual MR or leaflet injury risk. Annular calcification can also reduce valve area.
Baseline Mitral Valve Area
TEER intentionally creates a double-orifice valve and can increase transmitral gradient. A small baseline valve area or pre-existing stenosis raises the risk of clinically important post-TEER mitral stenosis.
Transmitral Gradient
The team measures the mean gradient before and after each clip. Additional clips may reduce MR but raise the gradient, creating a trade-off between regurgitation reduction and stenosis.
Pulmonary Hypertension
Pulmonary pressure reflects disease burden and can improve when MR is reduced, but severe fixed pulmonary vascular disease can limit benefit and increase procedural risk.
Right-Ventricular Function
Advanced right-ventricular dysfunction and severe tricuspid regurgitation can indicate late-stage disease. These findings should be incorporated into the expected-benefit discussion.
Coronary Artery Disease
Coronary disease should be assessed and treated when appropriate. Patients requiring surgical revascularization may be better served by CABG with surgical mitral treatment rather than isolated TEER.
Atrial Fibrillation
AF is common in MR and may contribute to atrial functional MR. Rate/rhythm strategy and anticoagulation are managed separately from the clip procedure.
Pre-Procedure Blood Tests
Blood count, kidney function, electrolytes, coagulation and other routine tests assess procedural fitness. Anemia, infection and anticoagulant management should be addressed before intervention.
Dental and Infection Assessment
Active systemic infection is a contraindication to elective device implantation. Good dental health and prompt treatment of infection are important because device-related endocarditis, though uncommon, can be serious.
Heart Team Evaluation
High-quality selection involves structural interventional cardiology, mitral cardiac surgery, imaging and heart-failure expertise. The team should compare TEER with repair, replacement and continued medical/device therapy.
Why a Mitral Repair Surgeon Should Be Involved
In degenerative MR, a specialist surgeon can estimate whether durable repair is achievable. TEER should not be chosen merely because it is less invasive if a low-risk patient has an excellent surgical repair option.
Tests and Assessment at a Glance
| Test | What it shows | Key points to ask about |
|---|---|---|
| Transthoracic echocardiography | MR severity, ventricular and atrial size, pulmonary pressure, tricuspid regurgitation and other valve disease | MR severity should be integrated from multiple measurements |
| TEE and 3D TEE | Leaflet length, flail or prolapse, jet location, calcification, clefts and baseline mitral valve area | Central to TEER planning; original images matter more than the written report |
| Leaflet and jet assessment | Flail gap and width, calcification in the grasping zone, central or noncentral jet | Determines technical feasibility and expected residual MR |
| Mitral valve area and gradient | Baseline valve area and transmitral gradient | A small valve area raises the risk of mitral stenosis after clipping |
| Pulmonary and right-heart assessment | Pulmonary hypertension, right-ventricular function and tricuspid regurgitation | Advanced findings can limit benefit |
| Coronary assessment | Coronary disease that may need treatment | Patients needing surgical revascularization may be better served by CABG with surgical mitral treatment |
| Blood tests, infection and dental review | Blood count, kidney function, electrolytes, coagulation, infection and dental health | Active systemic infection is a contraindication to elective device implantation |
| Heart Team evaluation | Structural cardiology, mitral surgery, imaging and heart-failure opinion | The team should compare TEER with repair, replacement and continued medical or device therapy |
The Procedure Step by Step
Femoral Venous Access
Unlike TAVI, TEER usually enters through a vein rather than an artery. A large venous sheath is advanced from the groin to the right atrium.
Transseptal Puncture
The operator crosses the interatrial septum at a carefully selected location to enter the left atrium. Puncture height and position are important for steering the clip above the mitral valve.
Steering the Delivery System
Under fluoroscopy and TEE, the system is aligned over the regurgitant jet. Precise orientation is essential so the clip arms are perpendicular to the leaflet coaptation line.
Leaflet Grasping
The clip is advanced into the left ventricle, retracted to capture both leaflets and closed. TEE confirms that adequate leaflet tissue is securely inserted.
Assessing the First Clip
The team evaluates residual MR, pulmonary-vein flow, transmitral gradient and leaflet insertion. If MR remains significant and the gradient permits, another clip may be considered.
Using Multiple Clips
Complex or broad jets may require two or more devices. Each additional clip can improve MR reduction but also reduces valve area, so the gradient must be monitored.
Final Device Release
The clip is released only after imaging confirms stable leaflet capture, acceptable MR reduction and an acceptable transmitral gradient.
Closing the Venous Access
The femoral venous access site is closed and the patient is monitored for bleeding. Venous complications are generally less common than large-bore arterial complications but still occur.
Role of General Anaesthesia
General anaesthesia is common because continuous TEE and precise transseptal/leaflet imaging are needed. Some centers use alternative sedation approaches in selected patients.
The Procedure and Hospital Stay at a Glance
| Stage | What happens | Key points to ask about |
|---|---|---|
| Femoral venous access | A large venous sheath is advanced from the groin to the right atrium | Usually a vein rather than an artery, unlike TAVI |
| Transseptal puncture | The septum is crossed to reach the left atrium | Puncture height and position matter for steering the clip |
| Steering the system | The delivery system is aligned over the regurgitant jet under fluoroscopy and TEE | Precise orientation is essential |
| Leaflet grasping | The clip is advanced into the ventricle, retracted to capture both leaflets and closed | TEE confirms secure leaflet insertion |
| Assessing the result | Residual MR, pulmonary-vein flow and transmitral gradient are measured | Another clip may be considered if the gradient permits |
| Device release and closure | The clip is released once the result is acceptable, then the venous site is closed | Monitored for bleeding afterwards |
| Anaesthesia | General anaesthesia is common because continuous TEE is needed | Some centres use alternative sedation in selected patients |
Results, Residual MR and Complications
Immediate Hemodynamic Effect
Successful TEER reduces regurgitant volume and left-atrial pressure. Patients can experience early improvement in breathlessness, although ventricular remodeling and functional recovery continue over time.
Residual MR
The goal is a clinically meaningful reduction, ideally to mild or less when feasible without excessive gradient. Residual moderate or greater MR is associated with less favorable outcomes.
Single-Leaflet Device Attachment
If the clip loses secure attachment to one leaflet, significant recurrent MR can occur. Management depends on anatomy and may involve another clip or surgery.
Leaflet Injury
Leaflet tear or perforation is uncommon but can worsen MR and complicate further catheter treatment. Emergency or later surgery may be required.
Mitral Stenosis After TEER
Excessive reduction of valve area can create a high transmitral gradient. This is why baseline valve area and intraprocedural gradient are essential to decision-making.
Cardiac Tamponade
Transseptal puncture or catheter manipulation can perforate cardiac structures, causing blood to collect around the heart. Immediate drainage and occasionally surgery are required.
Stroke and Embolism
Stroke is uncommon but possible from thrombus, air or catheter-related embolism. Anticoagulation during the procedure and meticulous technique reduce risk.
Bleeding and Vascular Complications
Groin bleeding, hematoma and venous injury can occur. Patients on anticoagulants or antiplatelet drugs require careful medication planning.
Atrial Septal Defect After TEER
The large transseptal sheath leaves a small communication between the atria. Most defects are observed; selected significant shunts may require closure.
Kidney Injury
TEER generally uses less contrast than many arterial structural procedures, but kidney injury can still occur from hemodynamic instability, medications or comorbidity.
Device Endocarditis
Infection involving a clip is rare but serious. Persistent fever or bacteremia after TEER requires prompt specialist assessment.
Need for Emergency Surgery
Emergency conversion to surgery is uncommon but can be necessary for severe leaflet injury, uncontrolled MR, tamponade or other catastrophic complications. Surgical backup remains important.
Results and Complications at a Glance
| Issue | What it can look like | What to ask or do |
|---|---|---|
| Residual MR | Leakage that remains after clipping | Residual moderate or greater MR is associated with less favorable outcomes |
| Single-leaflet device attachment | Clip detaches from one leaflet and MR returns | May need another clip or surgery |
| Leaflet injury | Tear or perforation of a leaflet | Uncommon; emergency or later surgery may be required |
| Mitral stenosis after | ||
| TEER | High transmitral gradient from reduced valve area | Baseline valve area and intraprocedural gradient guide decisions |
| Cardiac tamponade | Bleeding around the heart from perforation | Needs immediate drainage and occasionally surgery |
| Stroke and embolism | Thrombus, air or catheter-related embolism | Uncommon; procedural anticoagulation and technique reduce risk |
| Bleeding and vascular complications | Groin bleeding, hematoma or venous injury | Medicines are planned carefully beforehand |
| Atrial septal defect | Small communication left by the large sheath | Most are observed; significant shunts may need closure |
| Kidney injury, device endocarditis, emergency surgery | Rare but serious events | Confirm on-site surgical backup |
Hospital Recovery and Early Benefit for International Patients in India
Hospital Recovery for International Patients in India
Patients are monitored for rhythm, access-site bleeding, neurological status and heart failure. An uncomplicated stay is often about two to four days, depending on baseline condition.
Early Mobility
Because there is no sternotomy, mobilization is usually rapid after venous access hemostasis. Frail heart-failure patients may still need substantial rehabilitation.
Symptom Improvement
Many appropriately selected patients experience less breathlessness and better functional capacity. Benefit depends on adequate MR reduction and the severity of underlying ventricular disease.
Heart-Failure Admissions
In selected secondary MR populations, successful TEER can reduce recurrent heart-failure hospitalization. Outcomes depend strongly on patient selection and optimized background therapy.
Reverse Remodeling
Reduction in MR can lower volume overload and permit favorable chamber remodeling over time. The extent varies with MR mechanism and underlying cardiomyopathy.
What TEER Cannot Reverse
Advanced myocardial scar, severe fixed pulmonary vascular disease or end-stage right-heart dysfunction may not normalize even after technically successful MR reduction.
Recovery and Early Benefit at a Glance
| Topic | What it means | What to ask or do |
|---|---|---|
| Hospital recovery | Monitoring of rhythm, access-site bleeding, neurological status and heart failure | Often about 2-4 days if uncomplicated |
| Early mobility | Rapid mobilization after venous access hemostasis | Frail heart-failure patients may still need substantial rehabilitation |
| Symptom improvement | Less breathlessness and better functional capacity in many selected patients | Depends on adequate MR reduction and underlying ventricular disease |
| Heart-failure admissions | Fewer admissions in selected secondary MR groups | Depends on patient selection and optimized background therapy |
| Reverse remodeling | Chamber remodeling over time as volume overload falls | Varies with the MR mechanism and cardiomyopathy |
| What TEER cannot reverse | Advanced scar, fixed pulmonary vascular disease or end-stage right-heart dysfunction | Discuss realistic expectations before travel |
Antithrombotic Therapy, Follow-Up and Recurrent MR for International Patients in India
Post-Procedure Antithrombotic Therapy
Medication strategy is individualized according to atrial fibrillation, bleeding risk, existing anticoagulation and center protocol. Patients should leave India with a written regimen and duration.
Follow-Up Echocardiography for International Patients in India
A baseline post-TEER echo documents residual MR, gradient, ventricular function and pulmonary pressure. Repeat imaging is required to detect recurrent MR or stenosis.
Recurrent MR
MR can recur because of progressive disease, leaflet changes, device-related problems or ventricular remodeling. Treatment may include repeat TEER, surgery or medical management depending on anatomy.
Repeat TEER
A second catheter procedure can be feasible in selected patients with recurrent/residual MR if sufficient leaflet tissue and valve area remain.
Surgery After Failed TEER
Surgery remains possible after TEER, but previous clips can make repair more difficult and sometimes necessitate replacement. This possibility should be considered before the first procedure.
Follow-Up and Long-Term Care at a Glance
| Topic | What it means | What to ask or do |
|---|---|---|
| Antithrombotic therapy | Regimen individualized to AF, bleeding risk and existing anticoagulation | Leave India with a written regimen and duration |
| Follow-up echocardiography | Baseline post-TEER echo, then repeat imaging | Looks for recurrent MR or stenosis |
| Heart-failure treatment | Guideline-directed therapy continues, especially in secondary MR | The clip does not replace disease-modifying drugs |
| Recurrent MR | May need repeat TEER, surgery or medical management | Understand the plan before the first procedure |
| Repeat TEER | Possible if leaflet tissue and valve area remain sufficient | Depends on anatomy |
| Surgery after TEER | Possible, but prior clips can make repair harder and replacement more likely | Consider this before the first clip |
TEER versus Surgery and Valve Replacement
TEER vs Surgical Repair
TEER vs Surgical Repair
| Factor | TEER | Surgical Repair |
|---|---|---|
| Access | Transcatheter venous | Open/minimally invasive surgery |
| Heart-lung machine | No routine use | Yes |
| Recovery | Usually faster | Longer |
| Native valve | Preserved | Preserved |
| Annuloplasty ring | No | Usually part of durable repair |
| Best role | Selected high-risk/inoperable primary MR; selected secondary MR | Durable repairable degenerative MR in suitable surgical candidates |
| Residual MR | More likely | Often very low after successful expert repair |
| Future surgery | Possible but may be more complex | Future intervention depends on repair durability |
| Typical preference | Often higher-risk or frail patients, or selected heart-failure patients with secondary MR | Often lower-risk patients with a repairable degenerative valve |
TEER vs Mitral Valve Replacement
TEER preserves the native valve and avoids cardiopulmonary bypass but may leave residual MR and does not address all pathology. Replacement offers definitive elimination of native-valve regurgitation but is a major operation with prosthesis-related lifelong considerations.
Choosing Between Options at a Glance
| Option | What it involves | Key points to ask about |
|---|---|---|
| TEER/MitraClip | Catheter clip joins the mitral leaflets | Does not replace the valve or treat other problems; leaflet anatomy must suit it |
| Surgical mitral repair | Native valve reconstructed, usually with an annuloplasty ring | Often the durable choice for repairable degenerative MR in operable patients |
| Mitral valve replacement | Prosthesis replaces the valve | Definitive for native-valve MR but a major operation with lifelong prosthesis considerations |
| Optimized medical and device therapy | Heart-failure drugs, CRT and revascularization when indicated | Comes first in secondary MR |
| Combined surgery | CABG or other valve surgery with mitral treatment | Often preferable when more than one problem needs treatment |
Choosing Your Heart Team, Hospital and City for International Patients in India
Choosing a TEER Specialist for International Patients in India
Look for a structural interventional cardiologist with dedicated mitral experience and close collaboration with expert echocardiographers and mitral surgeons. Case volume and imaging skill strongly influence complex procedures.
Choosing the Hospital for International Patients in India
The center should have advanced 3D TEE, structural-heart intervention, cardiac surgery, anaesthesia, ICU, heart-failure services and emergency surgical capability.
Major Indian Treatment Hubs
Delhi NCR, Mumbai, Bengaluru, Chennai, Hyderabad and other tertiary cardiac centers offer structural mitral programs. Verify device availability and team-specific TEER experience.
Warning Signs of an Unreliable Offer for International Patients in India
Medical travel works best when the information you receive is specific, itemized and clinically sensible. Be cautious if you see any of the following:
Red Flags
- A clip offered without review of your original TEE images
- No distinction between primary and secondary MR, or no explanation of why TEER rather than surgery
- Secondary MR treated with a clip without evidence that heart-failure therapy is optimized
- No named structural interventional cardiologist, or no information on the team's mitral TEER volume
- No expert echocardiographer, mitral surgeon or on-site cardiac surgery for emergencies
- A quotation that does not name the device, the number of clips included or the price of an extra clip
- No discussion of residual MR, transmitral gradient or what happens if MR recurs
- A very low package price with the device, ICU days or complications excluded
- Pressure to travel while unstable, or to decide or pay quickly
What a Good International Patient Service Should Provide
A well-run programme should make the journey easier and safer at every stage:
- A named coordinator and a direct line to the clinical team before you travel
- Review of your actual TEE images and records by a Heart Team, with a written provisional opinion
- Honest discussion of alternatives, including surgical repair, replacement and optimized medical or device therapy
- Clarity about the exact device, the expected number of clips and the price of an additional clip
- An itemized written estimate covering the device, imaging, interventional fee, anaesthesia, cath or hybrid lab, ICU or room days and exclusions
- Information on cardiac surgery backup, ICU and heart-failure services
- A hospital letter for your medical visa application, and guidance for attendant visas
- Airport pick-up, assistance on arrival and accommodation near the hospital
- Interpreter support where needed
- A procedure report, device details, post-TEER echocardiogram, residual MR grade, transmitral gradient, medication plan and follow-up instructions when you leave
- A defined pathway after you return home, including a named cardiologist and heart-failure service
Expected Outcomes and What to Expect for International Patients in India
Expected Benefits and Limitations
TEER can reduce MR with substantially less physiological stress than open surgery. It is most valuable when the right patient, anatomy and timing are matched; it should not be used simply because the patient wishes to avoid surgery.
Around TEER: What to Expect
| Stage | What usually happens |
|---|---|
| Before the procedure | Remote review of your TEE images and records, then repeat assessment, Heart Team decision on TEER versus surgery or medical therapy, and final agreement on the plan and follow-up |
| Day of the procedure | Usually general anaesthesia with continuous TEE, access through a groin vein, clip placement and checks of residual MR and gradient before release |
| First days | Monitoring of rhythm, groin site, neurological status and heart failure, early mobilization, and discharge often after about 2-4 days |
| Early recovery in India | Post-procedure echocardiogram documenting residual MR and gradient, groin review and a stay near the hospital, commonly about 7-14 days in total |
| After you return home | Cardiologist follow-up, continued heart-failure therapy, antithrombotic treatment as prescribed, and repeat echocardiography to detect recurrent MR or stenosis |
Cost, Packages and Quotations for International Patients in India
Indicative MitraClip / TEER Cost for International Patients in India
| Scenario | Broad International-Patient Planning Range |
|---|---|
| Pre-TEER structural-heart evaluation + TEE | US$700-1,500+ |
| TEER with one clip/device | US$28,000-40,000+ |
| TEER requiring additional clip/device | US$35,000-50,000+ depending on device count |
| Complex TEER / prolonged hospitalization | Case-specific |
| Repeat TEER | Case-specific; depends on additional device requirements |
The implanted device is a major cost component. These figures are broad private international-patient planning estimates rather than guaranteed tariffs. Device availability, number of clips, hospital pricing and clinical complexity can substantially change the quotation.
What Should the TEER Package Include?
Clarify the exact device and number of clips included, structural cardiologist and imaging specialist fees, cardiac anaesthesia, cath/hybrid lab, TEE, ICU/CCU and room days, routine tests/medicines, vascular closure, post-procedure echo and complication policy. Ask how much an additional clip would add.
Why TEER Prices Differ
Cost varies with imported device pricing, number and type of clips, complexity of anatomy, procedure duration, hospital category, ICU stay and complications. A one-device quote should not be compared directly with a package that anticipates two devices.
TEER Cost for International Patients in India vs Other Countries
| Country | Broad Private/Self-Pay Planning Range | Approximate Saving vs India* |
|---|---|---|
| India | US$28,000-45,000+ | Baseline |
| USA | US$80,000-160,000+ | India may be ~44-83% lower |
| UK private | US$50,000-85,000+ | India may be ~10-67% lower |
| Australia private | US$55,000-90,000+ | India may be ~18-69% lower |
*Broad planning comparisons only. Device count, public/insurance coverage and package definitions vary substantially. Obtain matched written quotations.
Budgeting for the Whole Pathway, Not Just the Procedure
The procedure is only one part of the budget. Ask for the quotation, then add:
- A contingency for a complication, a longer hospital stay, or an extra few days in India
- An additional clip or device, if it turns out to be needed and the price is not fixed in advance
- The exact device and number of clips included, which should be named in the quotation
- TEE and other imaging, ICU or room days and blood products, if they are not fully included
- Pre-procedure tests: echocardiography, coronary studies and blood tests
- Return flights for you and a companion, with flexibility to change dates
- Accommodation near the hospital for the whole stay, commonly 7-14 days and longer if complications arise
- Local transport, meals and airport transfers
- Visa fees, travel insurance and any attendant visa costs
- Cardiology and heart-failure follow-up, echocardiography and medicines at home
Quotation Comparison Table for International Patients in India
| Item | Centre A | Centre B |
|---|---|---|
| MR mechanism/severity | ||
| TEER vs surgery rationale | ||
| Device/clip type | ||
| Number of clips included | ||
| TEE/imaging | ||
| Interventional fee | ||
| Anaesthesia | ||
| Cath/hybrid lab | ||
| ICU/room | ||
| Post-TEER echo | ||
| Extra clip price | ||
| Medicines/investigations | ||
| Complication exclusions | ||
| Total |
Your Journey: Records, Travel, Visa and Going Home
Remote Second Opinion Before Travel
Send TTE/TEE images and reports, ECG, coronary studies, heart-failure medication list and doses, CRT/device information, prior cardiac surgery records, kidney function and recent hospitalization history. For secondary MR, the team should document whether medical/device therapy is optimized.
Records Especially Important for TEER
Original TEE images are particularly valuable because candidacy depends on leaflet anatomy, not merely the written report. Prior surgical repair details, annuloplasty-ring information, pacemaker/CRT data and previous coronary angiography should also be provided when relevant.
Records Checklist
- Original TTE and TEE images and reports
- ECG
- Coronary studies
- Heart-failure medicines and doses
- CRT, pacemaker or device information
- Prior cardiac surgery or repair records
- Kidney function and recent hospitalizations
- Passport copy
Typical International-Patient Journey
After arrival, the Heart Team reconfirms MR severity, mechanism, symptoms and anatomy. TEE planning is finalized, TEER is performed, and the patient undergoes access-site, rhythm and heart-failure monitoring. Post-procedure echo documents residual MR and gradient before discharge.
How Long to Stay for International Patients in India
For an uncomplicated TEER procedure, approximately seven to fourteen days in India is a practical broad planning range including final assessment and early review. Frailty, advanced heart failure or procedural complications may require longer.
Flying After TEER
Long-haul travel should wait until the femoral venous site is stable, mobility is adequate, heart failure is controlled and post-procedure echo shows an acceptable result. Individual fit-to-fly advice is essential.
Airline and Travel Practicalities After TEER
Airline rules differ, so confirm each point with your airline and cardiologist before you fly:
| Topic | What to arrange |
|---|---|
| Fit-to-fly letter | Ask your cardiologist for written clearance stating the procedure, device and date, and carry it in hand luggage |
| Device details | Carry the device type, number of clips, procedure date and the post-procedure echocardiogram result |
| Blood-clot prevention | Ask for individualized advice on walking, hydration, compression stockings and any medicines on a long flight |
| Heart-failure and antithrombotic medicines | Carry all medicines in hand luggage in original packaging with a prescription, with extra supply in case of delay; do not stop any without advice |
| Groin site care | Avoid heavy lifting and straining; report any swelling, bleeding or leg pain |
| Warning symptoms | Know that severe breathlessness, stroke symptoms, fainting, fever or rapidly worsening swelling needs urgent medical help, before and during travel |
| Records and discharge papers | Carry the procedure report, discharge summary, post-TEER echocardiogram and contact details of the Heart Team |
| Flexible tickets and insurance | Book a flexible return and check what travel insurance covers for cardiac complications |
Medical Visa and Attendant for International Patients in India
Verify current Indian medical and medical attendant visa requirements for your nationality and obtain hospital documents where required. A companion is advisable, especially for frail or heart-failure patients. Current rules should be checked through official channels.
Follow-Up at Home
The home cardiologist should receive the procedure report, device details, post-TEER echo and medication plan. Secondary-MR patients must continue guideline-directed heart-failure therapy even after a successful clip.
Arranging Your Follow-Up Care at Home Before You Leave
Set up your home team before you travel and confirm it again before you fly home:
| Who | Role |
|---|---|
| Cardiologist | Directs medication, rhythm and echocardiographic follow-up, and reads your procedure report |
| Heart-failure service | Continues guideline-directed therapy, which TEER does not replace |
| Echocardiography service | Repeats imaging to detect recurrent MR or stenosis |
| Cardiac rehabilitation program | Provides monitored exercise, education and support |
| Emergency department with a named contact | Knows you have had a mitral clip and can see you urgently using your records |
| Family doctor | Reviews general health, kidney function, diabetes and blood pressure, and coordinates referrals |
| Overseas Heart Team | Teleconsultations, review of results and advice on the plan |
Hand-over Checklist
- Procedure report and discharge summary
- Device details and number of clips
- Post-TEER echocardiogram with residual MR grade and transmitral gradient
- Written fit-to-fly clearance
- Medication list and antithrombotic plan
- Groin site care instructions
- Heart-failure treatment plan
- Plan for repeat echocardiography
- Warning signs, emergency contacts and follow-up schedule
- Name of the cardiologist who will see you
Warning Signs
Urgent review is required for sudden severe breathlessness, stroke symptoms, fainting, persistent fever, rapidly worsening edema, major groin bleeding, sustained arrhythmia or a sudden decline in exercise tolerance.
Do Not Wait for an Overseas Reply
Sudden severe breathlessness, stroke symptoms (facial droop, weak arm, speech trouble), fainting, persistent fever, rapidly worsening swelling, major groin bleeding, sustained palpitations or a sudden decline in exercise tolerance needs urgent assessment where you are. Call emergency services or go to an emergency department. Tell the team you have had a mitral clip procedure, show your records, and contact your Heart Team afterwards.
Tools: Questions, Candidacy, FAQ and Checklist
Twenty Questions to Ask the TEER Heart Team
- Is my MR primary or secondary?
- Is my MR definitely severe?
- Why do I need intervention now?
- If primary MR, can an expert surgeon repair my valve durably?
- If secondary MR, is my heart-failure therapy fully optimized?
- Do I need CRT or revascularization first?
- Why is TEER better than surgery for me?
- What does my TEE show about leaflet anatomy?
- Where is the main regurgitant jet?
- Is there leaflet calcification in the grasping zone?
- What is my baseline mitral valve area and gradient?
- How many clips do you expect to use?
- What residual MR do you expect?
- What gradient would make you stop adding clips?
- What is my risk of single-leaflet attachment or leaflet injury?
- Could I need emergency surgery?
- How much TEER does this team perform?
- What happens if MR recurs?
- When can I fly home?
- Does the quote include additional clips if needed?
Who May Be a Good Medical-Travel Candidate?
A stable patient with confirmed severe MR, a multidisciplinary recommendation for TEER, favorable leaflet anatomy, sufficient time for evaluation and early follow-up, and reliable cardiology/heart-failure care at home may reasonably consider treatment in India.
Who Should Not Delay Local Emergency Care?
Cardiogenic shock, severe pulmonary edema, unstable arrhythmia, active endocarditis or other acute hemodynamic deterioration requires urgent local stabilization. International travel should not delay emergency treatment.
Frequently Asked Questions About MitraClip / TEER in India on MitraClip / Transcatheter Edge-to-Edge Repair (TEER) Procedure for International Patients in India
Is MitraClip the same as TEER?
MitraClip is a device used to perform TEER; TEER is the treatment concept.
Does TEER replace the mitral valve?
No. It clips the native leaflets together to reduce leakage.
Is it open-heart surgery?
No. It is catheter-based and usually uses femoral venous access.
Who benefits most?
Carefully selected severe MR patients in whom Heart Team assessment favors TEER over surgery or medical therapy alone.
Can a young low-risk patient with degenerative MR have TEER?
Technically sometimes, but expert surgical repair may provide a more durable strategy when operative risk is low.
What must happen before TEER for secondary MR?
Heart-failure therapy should be optimized and CRT/revascularization considered when indicated.
How many clips are used?
One or more depending on jet anatomy, residual MR and transmitral gradient.
Can too many clips cause stenosis?
Yes. Each clip reduces valve area, so the gradient is monitored.
What is single-leaflet device attachment?
A clip remains attached to only one leaflet, potentially causing recurrent MR.
How long does the procedure take?
Often a few hours, but complexity varies.
How long is hospital stay?
Often about two to four days if uncomplicated.
How long should I stay in India?
About seven to fourteen days is a practical broad range.
What does TEER cost in India?
Broadly about US$28,000-45,000+ for many private international-patient cases, with device count strongly affecting price.
Will my symptoms improve immediately?
Some patients improve early; functional recovery can continue over weeks to months.
Can MR come back?
Yes. Recurrent or residual MR can occur.
Can TEER be repeated?
Sometimes, if leaflet anatomy and valve area remain suitable.
Can I still have surgery later?
Yes, but prior clips can make repair more difficult and may lead to replacement.
Do I still need heart-failure medicines?
Yes, especially in secondary MR; TEER does not replace disease-modifying heart-failure therapy.
Can I fly after TEER?
Usually after stable early recovery and cardiologist clearance.
What records should I take home?
Procedure report, device details, post-TEER echo, medication plan and follow-up instructions.
Can I travel alone for TEER?
It is not advisable. Even though recovery is faster than after surgery, frail or heart-failure patients may need help with movement, medicines and transport, and a companion is valuable if a complication occurs in a foreign country.
What if I am too unwell to travel?
Follow your cardiologist's advice. Cardiogenic shock, severe pulmonary edema, unstable arrhythmia or active endocarditis need urgent local stabilization, and international travel should not delay emergency treatment.
Is a lower price a reason to choose a centre?
No. Compare the Heart Team, the team's mitral TEER volume, the imaging quality, the named device and number of clips, surgical backup and the follow-up plan first. A low package that excludes extra clips, ICU days or complications can end up costing more.
Can my home cardiologist follow me after TEER?
Often yes, but only if they have agreed in advance and received your procedure report, device details, post-TEER echocardiogram and medication plan.
International Patient TEER Checklist
Diagnosis
Primary vs secondary MRSevere MR confirmedSymptoms/NYHA classLVEF/LV sizePulmonary pressureRV/tricuspid status
Anatomy
TEE/3D TEEJet locationLeaflet lengthFlail/gapCalcificationMitral valve areaBaseline gradient
Treatment decision
Expert repair opinion if primary MRGDMT optimized if secondary MRCRT/revascularization if indicatedTEER vs surgery rationale
Hospital/team
Structural mitral operatorExpert echocardiographerMitral surgeonHeart-failure specialistCardiac anaesthesiaEmergency surgery
Cost
Device typeNumber of clips includedAdditional clip priceTEECath labAnaesthesiaICU/roomComplication policy
Travel
Visa7-14 day or individualized stayCompanionFlexible flightHome cardiologistHeart-failure follow-up
Before leaving India
Groin reviewPost-TEER echoResidual MR gradeTransmitral gradientMedication planDevice/procedure recordsFit-to-flyWarning signs
Final Perspective for International Patients
TEER is a major advance for selected patients with severe mitral regurgitation who need a less invasive option. Its value depends on careful distinction between primary and secondary MR, expert TEE assessment and a Heart Team willing to compare clipping honestly with surgical repair, replacement and optimized heart-failure treatment. For an international patient considering India, the strongest TEER program is not simply the center offering the lowest device package. It is the center that can demonstrate detailed mitral imaging, experienced clip implantation, expert surgical backup and disciplined measurement of both residual MR and transmitral gradient. A technically successful clip is only one part of long-term care. Secondary-MR patients still need comprehensive heart-failure therapy; all patients need echocardiographic surveillance; and recurrent MR must be recognized early. The best TEER decision preserves future options while delivering meaningful symptom and outcome benefit today.
Sources
- Mayo Clinic - Mitral valve regurgitation, diagnosis and treatment: https://www.mayoclinic.org/diseases-conditions/mitral-valve-regurgitation/diagnosis-treatment/drc-20350183
- Cleveland Clinic - Mitral valve disease: types, symptoms and treatment: https://my.clevelandclinic.org/health/treatments/17239-mitral-valve-disease-percutaneous-interventions
- Government of India - Indian Visa Online (e-Medical Visa and e-Medical Attendant Visa): https://indianvisaonline.gov.in/evisa/
Hero photo: “Health Health - Stethoscope” by Formulate Health, via Wikimedia Commons, licensed CC BY 2.0.